Indivior Pharmaceuticals Inc
INDV
Pozycja w akcjach
#3883
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Cena akcji
$34.01
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$4.24B
Zmiana (1 dzień)
4.81%
Zmiana (1 rok)
40.02%
Kraj
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategoria
Healthcare
Wskaźnik P/B dla Indivior Pharmaceuticals Inc (INDV)
Wskaźnik P/B na dzień October 2026 TTM: -20.59
Według najnowszych raportów finansowych i ceny akcji Indivior Pharmaceuticals Inc, obecny wskaźnik P/B (TTM) wynosi -20.59. Na koniec 2023 wynosił 31.28.
Historia wskaźnika P/B dla Indivior Pharmaceuticals Inc od 2016 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
